A detailed history of Dunhill Financial, LLC transactions in Incyte Corp stock. As of the latest transaction made, Dunhill Financial, LLC holds 38 shares of INCY stock, worth $2,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 20 90.0%
Holding current value
$2,883
Previous $1.18 Million 112.94%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$57.33 - $68.61 $1,031 - $1,234
18 Added 90.0%
38 $2.52 Million
Q2 2024

Aug 09, 2024

BUY
$51.18 - $63.75 $204 - $255
4 Added 25.0%
20 $1.18 Million
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $169 - $199
3 Added 23.08%
16 $910,000
Q4 2023

Feb 12, 2024

BUY
$52.16 - $64.19 $678 - $834
13 New
13 $835,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.